Loading...
SSKN is not a good buy right now for an impatient investor. The trend is decisively bearish (SMA200 > SMA20 > SMA5 with a negatively expanding MACD), and there are no Intellectia buy signals or near-term news catalysts to justify stepping in immediately. With price sitting just above support (~1.198) in a downtrend, the higher-probability outcome is more chop or another leg down before any durable reversal—so I would avoid buying here (or sell/exit if already holding).
Trend is bearish: moving averages are stacked down (SMA_200 > SMA_20 > SMA_5), signaling sustained downside momentum. MACD histogram (-0.00204) is below zero and negatively expanding, implying bearish momentum is strengthening rather than stabilizing. RSI_6 at 34.19 is weak and close to oversold, which can allow short bounces, but it is not a reversal signal by itself while MACD/MA structure stays bearish. Key levels: immediate support S1 ~1.198 (then S2 ~1.158); resistance/pivot 1.263, then 1.328. With post-market ~1.215, the stock is hovering just above support—poor location for an impatient long because a breakdown can be fast.
Gross margin improved to 60.38% (+0.48% YoY), showing some pricing/mix or cost control improvement. RSI near oversold can enable a short-term technical bounce, and pattern-based stats suggest a modest chance of small near-term upside (e.g., low-single-digit gains over week/month).
Fundamentals are weakening with sharp YoY revenue decline and deeper losses, which typically limits buyer confidence in micro/small caps.
Latest quarter: 2025/Q3. Revenue fell to $6.929M (-21.23% YoY). Net income was -$1.622M (down -21.79% YoY), and EPS was -0.36 (down -29.41% YoY). Despite a slight gross margin uptick to 60.38%, the overall growth trend is negative (shrinking sales and widening per-share losses), which does not support an aggressive buy-now decision.
No analyst rating or price target change data was provided, so there is no visible recent Wall Street upgrade/downgrade or target revision trend to lean on. Pros (if any): margin improvement could be viewed constructively. Cons: accelerating YoY revenue decline and continued losses, plus a technically bearish chart, would likely keep the professional view cautious/negative until a turnaround is evident.